Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
106.45
+3.52 (3.42%)
May 8, 2026, 9:49 AM EDT - Market open

Mirum Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-798.84-23.36-87.94-163.42-135.67-83.99
Depreciation & Amortization
25.0724.2423.6310.833.240.6
Stock-Based Compensation
91.8271.4248.4435.0227.0123.09
Other Adjustments
417.183.243.665.846.33-89.44
Change in Receivables
-44.11-48.06-11.43-43.97-20.73-
Changes in Inventories
-7.7-8.45-3.17-0.97-3.44-0.5
Changes in Accrued Expenses
95.6150.140.3130.787.6322.92
Changes in Other Operating Activities
50-13.32-3.13-5.05-4.51-5.18
Operating Cash Flow
-170.9855.8310.33-70.94-120.14-132.76
Operating Cash Flow Growth
-440.70%----
Capital Expenditures
-1.58-0.95-0.99-0.11-0.28-0.02
Purchases of Intangible Assets
-30-20-20---19
Purchases of Investments
-98.7-97.43-89.03-27.33-132.32-198.03
Proceeds from Sale of Investments
90.8874.4319.89153140.3157.6
Payments for Business Acquisitions
----212.76--
Other Investing Activities
-----108
Investing Cash Flow
-19.39-23.95-90.13-107.27.748.55
Long-Term Debt Issued
---305.3--
Net Long-Term Debt Issued (Repaid)
---305.3--
Issuance of Common Stock
303.8640.1417.7227.15114.649.01
Net Common Stock Issued (Repurchased)
303.8640.1417.7227.15114.649.01
Other Financing Activities
----195.86-5.5564.45
Financing Cash Flow
303.8640.1417.7336.6109.0973.47
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.93.22-1.3-0.130.01-
Net Cash Flow
114.3975.24-63.4158.32-3.34-10.75
Free Cash Flow
-172.5554.879.33-71.05-120.41-132.78
Free Cash Flow Growth
-488.01%----
FCF Margin
-30.29%10.53%2.77%-38.12%-156.26%-693.81%
Free Cash Flow Per Share
-3.181.090.20-1.74-3.54-4.38
Levered Free Cash Flow
-637.4428.27-31.29177.36-133.03-66.17
Unlevered Free Cash Flow
-636.427.49-31.99-74.35-122.67-155.67
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q